FFR Technologies

This channel includes news and new technology innovations for fractional flow reserve (FFR) wires, catheters and systems used to measure blood flow across a coronary lesion to determine if a stent is needed or if the plaque stenosis can be treated medically. The section includes iFR, instantaneous wave-free ratio, systems used in the cath lab and noninvasive FFR technologies including computed tomography-FFR. This is also referred to as CT-FFR or FFR-CT.

News | FFR Technologies

January 4, 2022 - Pie Medical Imaging (PMI), a global leader in cardiac imaging, part of the Esaote Group, recently ...

Home January 04, 2022
Home
News | Cath Lab

December 14, 2021 — RSIP Vision, a medical imaging company applying advanced artificial intelligence (AI) and computer ...

Home December 14, 2021
Home
News | FFR Technologies

December 13, 2021 - HeartFlow Inc., the leader in revolutionizing precision heart care, today announced it has submitted ...

Home December 13, 2021
Home
News | FFR Technologies

November 9, 2021 — The primary results of the Fractional Flow Reserve Versus Angiography for Multivessel Evaluation ...

Home November 09, 2021
Home
News | FFR Technologies

November 9, 2021 — Use of a novel technique called the quantitative flow ratio (QFR) to precisely identify and measure ...

Home November 09, 2021
Home
News | FFR Technologies

September 8, 2021 — Adding systematic fractional flow reserve (FFR) assessment to coronary angiography does not reduce ...

Home September 08, 2021
Home
News | FFR Technologies

July 26, 2021 – CathWorks announced that the Japanese Ministry of Health, Labour and Welfare (MHLW) has approved the ...

Home July 26, 2021
Home
News | Cath Lab

July 22, 2021 — Medis Medical Imaging is partnering with CORRIB Core Lab and Sinomed in randomized clinical trial of ...

Home July 22, 2021
Home
News | FFR Technologies

July 15, 2021 — HeartFlow, which has commercialized noninvasive computed tomography derived fractional flow reserve (FFR ...

Home July 15, 2021
Home
News | FFR Technologies

June 22, 2021 – Philips Healthcare announced the official start of the DEFINE GPS study, with the first patient being ...

Home June 22, 2021
Home
Some of the top technology news from ACC 2021. Top left, the LAAOS III trial showed benefit when surgeons seal off the LAA during other open heart procedures. Bottom left, the ReCor Paradise renal denervation system helped lower blood pressure in patients who did not respond to medication. Top right, for patients with both heart failure and AFib it makes no differences is therapy is focused on controlling the heart rhythm or heart rate. Bottom right, the FLOWER-MI trial found no benefit to FFR-guided PCI.
Feature | ACC | By Dave Fornell, Editor

Here are the top 10 takeaways from the late-breaking studies on cardiovascular technologies presented at the 2021 Americ ...

Home June 08, 2021
Home
News | FFR Technologies

May 17, 2021 — In patients who received a coronary stent for an ST-elevation myocardial infarction (STEMI) heart attack ...

Home May 17, 2021
Home
News | Artificial Intelligence

May 12, 2021 — HeartFlow, Inc., a leader in revolutionizing precision heartcare, today announced that the National ...

Home May 12, 2021
Home
Videos | FFR Technologies

This is an example of the Medis Medical Imaging Quantitative Flow Ratio (QFR) system that offers a fractional flow ...

Home December 16, 2020
Home
News | FFR Technologies

December 16, 2020 – Acist Medical Systems Inc. announced a formal distribution partnership with Medis Medical Imaging to ...

Home December 16, 2020
Home
Subscribe Now